SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-023128
Filing Date
2024-07-22
Accepted
2024-07-22 08:12:11
Documents
15
Period of Report
2024-07-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sava20240721_8k.htm   iXBRL 8-K 33443
2 EXHIBIT 99.1 ex_701112.htm EX-99.1 17839
  Complete submission text file 0001437749-24-023128.txt   211194

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sava-20240722.xsd EX-101.SCH 3900
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sava-20240722_def.xml EX-101.DEF 13839
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sava-20240722_lab.xml EX-101.LAB 18243
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sava-20240722_pre.xml EX-101.PRE 13871
17 EXTRACTED XBRL INSTANCE DOCUMENT sava20240721_8k_htm.xml XML 4937
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41905 | Film No.: 241129307
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)